IDEXX Laboratories Inc (IDXX) (Q3 2026) Earnings Call Highlights: Raised Outlook, Record ...
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- IDXX Idexx Laboratories+30.2% 15d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that IDEXX Laboratories belongs to, so it often moves with news about it.
- LNTH Lantheus Holdings+0.7% 17d
Lantheus Holdings is a peer of IDEXX Laboratories in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- NEOG Neogen-2.5% 30d
Neogen is a peer of IDEXX Laboratories in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- LLY Eli Lilly and+15.5% 30d
Eli Lilly and is a large health company like IDEXX Laboratories; big names in a sector often move together.
- JNJ Johnson & Johnson+0.1% 30d
Johnson & Johnson is a large health company like IDEXX Laboratories; big names in a sector often move together.
- ABBV AbbVie+9.0% 30d
AbbVie is a large health company like IDEXX Laboratories; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| IDXX | -16.54% | -14.27% | base | +0.02% | +4.13% | -0.14% | +0.62% |
| XLV | -2.95% | -0.31% | base | -0.34% | +2.73% | +0.31% | +0.13% |
| LNTH | -0.17% | +0.01% | base | +0.46% | +0.81% | +0.38% | +0.28% |
| NEOG | +5.28% | +3.55% | base | +2.37% | +5.24% | -1.27% | -0.55% |
| LLY | -9.22% | -2.71% | base | -0.17% | +0.45% | -2.64% | -4.04% |
| JNJ | -0.68% | +1.70% | base | -1.63% | +2.13% | +0.67% | +2.13% |
| ABBV | -0.84% | +0.67% | base | -1.01% | +1.62% | +0.12% | +0.94% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
IDEXX Laboratories Inc (IDXX) (Q3 2026) Earnings Call Highlights: Raised Outlook, Record ... Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | -1.01% | final price |
| ABBV | the next day | +1.62% | final price |
| ABBV | two days later | +0.12% | final price |
| ABBV | three days later | +0.94% | final price |
| ABBV | three days earlier | +0.67% | final price |
| ABBV | five days earlier | -0.84% | final price |
| IDXX | that day | +0.02% | final price |
| IDXX | the next day | +4.13% | final price |
| IDXX | two days later | -0.14% | final price |
| IDXX | three days later | +0.62% | final price |
| IDXX | three days earlier | -14.27% | final price |
| IDXX | five days earlier | -16.54% | final price |
| JNJ | that day | -1.63% | final price |
| JNJ | the next day | +2.13% | final price |
| JNJ | two days later | +0.67% | final price |
| JNJ | three days later | +2.13% | final price |
| JNJ | three days earlier | +1.70% | final price |
| JNJ | five days earlier | -0.68% | final price |
| LLY | that day | -0.17% | final price |
| LLY | the next day | +0.45% | final price |
| LLY | two days later | -2.64% | final price |
| LLY | three days later | -4.04% | final price |
| LLY | three days earlier | -2.71% | final price |
| LLY | five days earlier | -9.22% | final price |
| LNTH | that day | +0.46% | final price |
| LNTH | the next day | +0.81% | final price |
| LNTH | two days later | +0.38% | final price |
| LNTH | three days later | +0.28% | final price |
| LNTH | three days earlier | +0.01% | final price |
| LNTH | five days earlier | -0.17% | final price |
| NEOG | that day | +2.37% | final price |
| NEOG | the next day | +5.24% | final price |
| NEOG | two days later | -1.27% | final price |
| NEOG | three days later | -0.55% | final price |
| NEOG | three days earlier | +3.55% | final price |
| NEOG | five days earlier | +5.28% | final price |
| XLV | that day | -0.34% | final price |
| XLV | the next day | +2.73% | final price |
| XLV | two days later | +0.31% | final price |
| XLV | three days later | +0.13% | final price |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 33 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 49 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“IDEXX Laboratories Inc (IDXX) (Q3 2026) Earnings Call Highlights: Raised Outlook, Record ...” scores 12 out of 100. The score uses 1 sources.